p.onwuka
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 30 September 2024 · last posted 3d
79 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #70 · Sourcing › Independent verification · 25 Jul 2026 · 5 likes On post #66 — agreed on the reasoning, with one qualification. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #64 · Practice › Side effects · 21 Jul 2026 · 1 like Worth separating two things that post #60 runs together. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
-
Tracking a shortage from primary sources rather than rumour Replied, post #112 · Access › Shortages · 19 Jul 2026 · 0 likes post #111 is right about the mechanism and I think understates the practical bit. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
Impurity thresholds: where the common numbers come from Replied, post #4 · Analytics › Impurities & related substances · 13 Jul 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #2 · Compounds › Tirzepatide · 10 Jul 2026 · 5 likes Coming back to the opening post, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations…
-
Coming back to: A structured critique template this community uses Replied, post #54 · Evidence › Study critique · 9 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #65 · Access › International · 8 Jul 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Restarting after a long gap: what the labelling implies Replied, post #6 · Practice › Dosing & titration · 30 Jun 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: what we got wrong in an earlier session Replied, post #29 · Evidence › Journal club · 25 Jun 2026 · 1 like post #28 is right about the mechanism and I think understates the practical bit. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The…
-
Follow-up: Reading an interaction checker output critically Replied, post #16 · Practice › Interactions · 23 Jun 2026 · 1 like Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #35 · Research Methods › Statistics · 22 Jun 2026 · 7 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #22 · Sourcing › Red flags · 3 Jun 2026 · 14 likes post #21 answers the question as asked. The question underneath it is different. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
Journal club: LEADER as the historical anchor Replied, post #78 · Evidence › Journal club · 23 May 2026 · 8 likes On post #74 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #27 · Compounds › Semaglutide · 15 May 2026 · 3 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #62 · Evidence › Journal club · 13 May 2026 · 24 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Citation sweep results: how many references did not say what was claimed Replied, post #85 · Meta › Wiki maintenance · 27 Apr 2026 · 6 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #60 · Evidence › Trials · 26 Apr 2026 · 6 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Publication bias detection and its low power — does this still hold? Replied, post #25 · Evidence › Meta-analyses · 21 Apr 2026 · 15 likes I read post #23 twice before replying, because I had assumed the opposite. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating…
-
An 18-month record including the parts that went badly Started this topic · Outcomes › Progress reports · 17 Apr 2026 · 27 likes An 18-month record including the parts that went badly — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated,…
-
Spike-and-recover accuracy for a peptide assay Replied, post #60 · Analytics › Method validation · 9 Apr 2026 · 16 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #53 · Data & Tools › Calculators · 8 Apr 2026 · 0 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #26 · Compounds › Semaglutide · 28 Mar 2026 · 8 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #39 · Data & Tools › Datasets · 18 Mar 2026 · 3 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Dead volume across syringe and needle combinations Replied, post #81 · Devices › Syringes & needles · 2 Mar 2026 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #75 · Evidence › Study critique · 22 Feb 2026 · 22 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #48 · Practice › Side effects · 20 Feb 2026 · 2 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #44 · Regional › UK & Ireland · 16 Feb 2026 · 2 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #125 · Analytics › Mass spectrometry · 16 Feb 2026 · 18 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #28 · Practice › Storage & stability · 16 Jan 2026 · 6 likes Coming back to post #26, because the follow-up matters more than the original answer. Vial integrity: once a vial is entered with a needle repeatedly, the rubber…
-
Reverse causation in a cohort study of weight and outcome Replied, post #11 · Evidence › Study critique · 1 Jan 2026 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #15 · Sourcing › Vendor reports · 28 Dec 2025 · 12 likes Coming back to post #13, because the follow-up matters more than the original answer. Structured report format: compound, lot, independent testing service, method as…
-
Substitution between formats during a shortage Replied, post #119 · Access › Shortages · 19 Dec 2025 · 13 likes post #118 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Tracking a preprint to publication: a worked example Replied, post #120 · Evidence › Preprints · 12 Dec 2025 · 30 likes This follows post #117 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #50 · Practice › Reconstitution · 25 Nov 2025 · 12 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Adolescents: a distinct evidence base — one year on Replied, post #34 · Clinical › Special populations · 15 Nov 2025 · 31 likes This follows post #31 rather than contradicting it. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further.…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #84 · Start Here › How to Ask · 10 Nov 2025 · 24 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Comparing my trajectory with the trial curves, carefully Replied, post #72 · Outcomes › Progress reports · 6 Nov 2025 · 19 likes post #71 is right about the mechanism and I think understates the practical bit. Protein intake and resistance training: both self-reported and therefore optimistic in…
-
Liver enzymes drifting down and what that usually means Replied, post #23 · Clinical › Bloodwork · 30 Oct 2025 · 3 likes On post #19 — agreed on the reasoning, with one qualification. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #83 · Start Here › Welcome · 20 Oct 2025 · 23 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #81 · Analytics › Home & field testing · 19 Oct 2025 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #68 · Start Here › Welcome · 19 Oct 2025 · 2 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #64 · Analytics › HPLC & UHPLC · 14 Oct 2025 · 28 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #67 · Lounge › Off topic · 30 Sep 2025 · 3 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #75 · Practice › Administration · 23 Sep 2025 · 20 likes Picking up post #72: that is the part I would want checked first. Drawing up with one needle and injecting with another: a reasonable practice if you have extra…
-
Payment method and the leverage it gives you, ranked Replied, post #19 · Sourcing › Payments · 16 Sep 2025 · 1 like Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #46 · Practice › Storage & stability · 5 Sep 2025 · 19 likes On post #42 — agreed on the reasoning, with one qualification. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the…
-
Are there stupid questions here? A staff answer, at length Replied, post #151 · Start Here › Welcome · 4 Sep 2025 · 3 likes I read post #149 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #53 · Analytics › HPLC & UHPLC · 30 Aug 2025 · 5 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Lyophilisation and why the cake looks the way it does Replied, post #12 · Pharmacology › Formulation chemistry · 15 Aug 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What a documentation review can and cannot tell you Replied, post #73 · Sourcing › Independent verification · 14 Aug 2025 · 3 likes Coming back to post #71, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Are there stupid questions here? A staff answer, at length Replied, post #59 · Start Here › Welcome · 10 Aug 2025 · 29 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
A ten-fold dose error caught before injection — one year on Replied, post #68 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Reading units correctly: look at the marking from the side, not from above or…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #26 · Compounds › Retatrutide · 28 Jul 2025 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Dose escalation in the published trials: the protocols started at lower doses and…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #47 · Access › Insurance & coverage · 17 Jul 2025 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A field-by-field walk through a certificate of analysis Replied, post #6 · Analytics › COA interpretation · 14 Jul 2025 · 22 likes Worth separating two things that post #2 runs together. Purity and content are different measurements: purity tells you what proportion of the detected material is the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #79 · Practice › Reconstitution · 1 Jul 2025 · 3 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #62 · Compounds › Repair & healing peptides · 25 Jun 2025 · 0 likes Worth separating two things that post #58 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Asking about a compound your prescriber has not heard of Replied, post #75 · Clinical › Prescriber conversations · 24 Jun 2025 · 0 likes This follows post #72 rather than contradicting it. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #106 · Access › Insurance & coverage · 14 Jun 2025 · 21 likes post #105 is right about the mechanism and I think understates the practical bit. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Coming back to: Getting a referral rather than a refusal Replied, post #67 · Clinical › Prescriber conversations · 14 Jun 2025 · 26 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Titrating on tolerability rather than on the calendar Started this topic · Practice › Dosing & titration · 16 May 2025 · 42 likes On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion. I have read the maintained page on this and I…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #31 · Compounds › Retatrutide · 28 Apr 2025 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #28 · Compounds › Retatrutide · 22 Mar 2025 · 22 likes Worth separating two things that post #24 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #21 · Clinical › Comorbidities · 25 Feb 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #3 · Access › Pricing · 2 Feb 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #24 · Sourcing › Vendor reports · 19 Jan 2025 · 26 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
Canadian access and provincial variation Started this topic · Regional › North America · 17 Jan 2025 · 16 likes Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Documenting an access outcome, dated,…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #30 · Data & Tools › Calculators · 25 Dec 2024 · 0 likes Picking up post #27: that is the part I would want checked first. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #30 · Wellbeing › Mental health · 23 Dec 2024 · 0 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
US compounding rules and how they changed Replied, post #63 · Regional › North America · 8 Nov 2024 · 0 likes Worth separating two things that post #59 runs together. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #17 · Sourcing › Independent verification · 2 Nov 2024 · 5 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Pen wastage and its effect on real cost Replied, post #29 · Access › Pricing · 28 Sep 2024 · 22 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #16 · Compounds › Semaglutide · 26 Sep 2024 · 0 likes This follows post #13 rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
-
Reading a meta-analysis you disagree with, fairly Replied, post #14 · Evidence › Meta-analyses · 31 Aug 2024 · 5 likes post #13 is right about the mechanism and I think understates the practical bit. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a…
-
Correlation in a self-tracked dataset: what it can support Replied, post #145 · Research Methods › Statistics · 25 Aug 2024 · 14 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Guidelines revision: what changed and why Replied, post #117 · Meta › Announcements · 28 Jul 2024 · 1 like Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #28 · Safety › Contraindications · 24 Jul 2024 · 10 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #32 · Practice › Dosing & titration · 23 Jul 2024 · 15 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Reading a meta-analysis you disagree with, fairly Replied, post #3 · Evidence › Meta-analyses · 1 Jul 2024 · 2 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…